{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:52:47Z","timestamp":1777794767207,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier","isbn-type":[{"value":"9780443430862","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acr.2026.01.004","type":"book-chapter","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:38:29Z","timestamp":1770241109000},"page":"289-316","source":"Crossref","is-referenced-by-count":0,"title":["Patient-centric approaches and personalized nanomedicine in skin cancer"],"prefix":"10.1016","author":[{"given":"Umesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshita","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garima","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satbir Singh","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0702a01","article-title":"Epidemiological trends in skin cancer","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatology Practical & Conceptual"},{"key":"10.1016\/bs.acr.2026.01.004_bib3","series-title":"Cancer in Australia 2021","author":"Australian Institute of Health and Welfare (AIHW)","year":"2021"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making\u2014pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/b309043b","article-title":"Dendrimers in drug research","volume":"33","author":"Boas","year":"2004","journal-title":"Chemical Society Reviews"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib8","first-page":"145","article-title":"Mobile teledermatology for skin cancer screening: Diagnostic accuracy of a mobile phone app","volume":"158","author":"Brinker","year":"2022","journal-title":"JAMA Dermatology"},{"key":"10.1016\/bs.acr.2026.01.004_bib9","series-title":"Where\u00a0are the patients in decision-making about their own care?","author":"Coulter","year":"2015"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng1002-229","article-title":"Top ten biotechnologies for improving health in developing countries","volume":"32","author":"Daar","year":"2007","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"Journal of Controlled Release"},{"issue":"6892","key":"10.1016\/bs.acr.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"9919","key":"10.1016\/bs.acr.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13012-016-0480-9","article-title":"Implementing shared decision-making: Consider all the consequences","volume":"7","author":"Elwyn","year":"2012","journal-title":"Implementation Science"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1370\/afm.1239","article-title":"The values and value of patient-centered care","volume":"9","author":"Epstein","year":"2011","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/bs.acr.2026.01.004_bib16","article-title":"Digital health and nanomedicine convergence: Perspectives for personalized skin cancer care","volume":"34","author":"Fernandes","year":"2021","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib17","first-page":"555","article-title":"The ethics of information: A brief history and overview","volume":"28","author":"Floridi","year":"2018","journal-title":"Minds and Machines"},{"issue":"10","key":"10.1016\/bs.acr.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/bs.acr.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1377\/hlthaff.2017.1624","article-title":"Precision medicine: From science to value","volume":"37","author":"Ginsburg","year":"2018","journal-title":"Health Affairs"},{"issue":"7","key":"10.1016\/bs.acr.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/annonc\/mdi211","article-title":"Communicating prognosis in cancer care: A systematic review of the literature","volume":"16","author":"Hagerty","year":"2005","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti\u2013PD-1) in melanoma","volume":"369","author":"Hamid","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"7528","key":"10.1016\/bs.acr.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"issue":"541","key":"10.1016\/bs.acr.2026.01.004_bib24","article-title":"Photodynamic therapy synergizes with immune checkpoint blockade to elicit antitumor immunity","volume":"12","author":"Huang","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"14","key":"10.1016\/bs.acr.2026.01.004_bib25","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1021\/jp057170o","article-title":"Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine","volume":"110","author":"Jain","year":"2012","journal-title":"The Journal of Physical Chemistry. B"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chemical Reviews"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.004_bib27","first-page":"199","article-title":"The paradox of precision medicine","volume":"9","author":"Kimmelman","year":"2012","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"1\u20132","key":"10.1016\/bs.acr.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.10.038","article-title":"Potential use of nanoparticles for transcutaneous vaccine delivery: Effect of particle size and charge","volume":"275","author":"Kohli","year":"2004","journal-title":"International Journal of Pharmaceutics"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.004_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.acr.2026.01.004_bib30","first-page":"35","article-title":"Gene editing in cancer therapy: A new era for personalized medicine","volume":"170","author":"Li","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib31","first-page":"324","article-title":"Nanoparticle delivery of anti-PD-L1 peptide for cancer immunotherapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Letters"},{"issue":"7","key":"10.1016\/bs.acr.2026.01.004_bib32","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2020","journal-title":"Chemical Society Reviews"},{"issue":"5","key":"10.1016\/bs.acr.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib34","first-page":"383","article-title":"BRAF mutation, gene expression and melanoma prognosis","volume":"34","author":"Mann","year":"2003","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib35","article-title":"Deep learning for healthcare: Review, opportunities and challenges","volume":"23","author":"Miotto","year":"2022","journal-title":"Briefings in Bioinformatics"},{"issue":"12","key":"10.1016\/bs.acr.2026.01.004_bib36","first-page":"705","article-title":"Complement activation-related pseudoallergy: How to avoid it and yet benefit from immunostimulatory nanoparticles","volume":"6","author":"Moghimi","year":"2011","journal-title":"Nature Nanotechnology"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib37","first-page":"659","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients","volume":"156","author":"Moloney","year":"2017","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870440290001494","article-title":"The revised illness perception questionnaire (IPQ-R)","volume":"17","author":"Moss-Morris","year":"2013","journal-title":"Psychology and Health"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.004_bib39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","article-title":"Ultraviolet radiation and skin cancer","volume":"49","author":"Narayanan","year":"2010","journal-title":"International Journal of Dermatology"},{"issue":"7326","key":"10.1016\/bs.acr.2026.01.004_bib40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to BRAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"Nazarian","year":"2010","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/bs.acr.2026.01.004_bib41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"International Journal of Pharmaceutics"},{"issue":"12","key":"10.1016\/bs.acr.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nature Nanotechnology"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1077558712465774","article-title":"Patient-centered care and outcomes: A systematic review of the literature","volume":"70","author":"Rathert","year":"2013","journal-title":"Medical Care Research and Review"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib44","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.004_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nature Nanotechnology"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2012","journal-title":"Nature Reviews. Cancer"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.004_bib47","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6603707","article-title":"Exploiting nanotechnology to target cancer","volume":"96","author":"Sengupta","year":"2007","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.acr.2026.01.004_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib49","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: a Cancer Journal for Clinicians"},{"key":"10.1016\/bs.acr.2026.01.004_bib50","unstructured":"Skin Cancer Foundation. (2022). Skin cancer facts & statistics. Retrieved from www.skincancer.org."},{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001431.pub5","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"2017","author":"Stacey","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.acr.2026.01.004_bib52","article-title":"Cancer nanomedicine for combination cancer immunotherapy: Promises and challenges","volume":"12","author":"Tian","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.004_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: The convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.acr.2026.01.004_bib54","series-title":"Deep medicine: How artificial intelligence can make healthcare human again","author":"Topol","year":"2019"},{"issue":"11","key":"10.1016\/bs.acr.2026.01.004_bib55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2011","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"11","key":"10.1016\/bs.acr.2026.01.004_bib56","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nature Nanotechnology"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.004_bib57","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1016\/bs.acr.2026.01.004_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nature Reviews Materials"},{"issue":"7418","key":"10.1016\/bs.acr.2026.01.004_bib59","first-page":"794","article-title":"Basal cell carcinoma","volume":"327","author":"Wong","year":"2003","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1016\/bs.acr.2026.01.004_bib60","unstructured":"World Health Organization (WHO). (2020). Skin cancers. Retrieved from https:\/\/www.who.int."},{"key":"10.1016\/bs.acr.2026.01.004_bib61","first-page":"282","article-title":"pH-sensitive nanoparticles for targeted delivery of BRAF inhibitor in BRAF-mutant melanoma","volume":"72","author":"Yang","year":"2018","journal-title":"Acta Biomaterialia"},{"key":"10.1016\/bs.acr.2026.01.004_bib62","article-title":"Biodegradable polymeric nanoparticles for cancer therapy: A focus on potential clinical translation","volume":"225","author":"Zhao","year":"2021","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.acr.2026.01.004_bib63","first-page":"212","article-title":"Enhanced anticancer activity of nanopreparations of paclitaxel and cisplatin in an MMP2-sensitive poly(ethylene glycol)-peptide conjugate","volume":"239","author":"Zhu","year":"2017","journal-title":"Journal of Controlled Release"}],"container-title":["Advances in Cancer Research","Innovative Nanotechnology: Transforming Skin Cancer Diagnosis and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:14:41Z","timestamp":1777493681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X26000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443430862"],"references-count":63,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2026.01.004","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}